• Activity Title

    Start Activity


    Adaptive Servoventilation in Central Sleep Apnoea:

    Current Knowledge and Future Perspectives

     

  • Statement of Need/Program Overview

    Sleep related breathing disturbances can be differentiated in various phenotypes, especially obstructive sleep apnoea, central sleep apnoea and hypoventilation disorders. Central breathing disturbances represent about 10% of the population of sleep apnoea patients. Several underlying diseases predispose to central sleep apnoea, with heart failure with reduced and preserved ejection fraction being the most prevalent comorbidities. Several studies have shown the impact of central sleep apnoea on mortality of heart failure patients. CPAP and oxygen may reduce central breathing disturbances by about 50% and data on long-term outcome are missing. Since its introduction into clinical practice, adaptive servo ventilation has been studied in several cohorts and randomized controlled trials. It normalizes central breathing disturbances, improves oxygen saturation and left ventricular ejection fraction. However, data on long-term outcome are controversial. Therefore, this program will discuss different algorithms of adaptive servo ventilation, the results of cohort studies and randomized controlled trials and discuss current options and future perspectives.

  • Target Audience

    This activity is intended for medical professionals who have a clinical interest in the management of respiratory patients as seen by the following medical specialists: Pulmonologists, Pneumologists, Respirologists, Respiratory Physiotherapists, Respiratory Therapists (Hospital, Home), Thoracic Surgeons, Home Healthcare Providers, Critical Care Medicine Specialists, Internal Medicine Specialists, Primary Care Physicians (General and Family Practitioners), Advanced Practice Nurses, Nurse Practitioners, Physicians Assistants, Managed Care Medical Directors, and other Practitioners and Payers.

  • Educational Objectives

    After completing this activity, the participant should be better able to:

    1.    Describe the heterogeneity of phenotypes of central sleep apnoea.
    2.    Discuss the pathophysiology of central sleep apnoea in heart failure.
    3.    Explain the algorithm of adaptive servoventilation and its differences.
    4.    Summarize the impact of central sleep apnoea on outcome of heart failure patients.
    5.   Identify differences in outcomes of large randomized controlled trials and cohort studies.

  • Faculty

    Prof. Dr. med. Winfried J. Randerath
    Professor of Medicine
    Clinic of Pneumology and Allergology Center for Sleep Medicine and Respiratory Care
    Bethanien Hospital
    Solingen, Germany 

  • American Association for Respiratory Care (AARC) Accreditation

    AARC Designation Statement

    This Non-traditional program has been approved for 1.0 contact hour Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care; 9425 N. MacArthur Boulevard, Suite 100, Irving TX 75063

  • Term Offering - AARC / CRCE

    This activity was released on August 25, 2025 and is valid for two years. Requests for credit must be made no later than August 25, 2027.

    The above term offering is for the following accreditation: AARC.

  • Other Allied Healthcare Professional

    Participation Statement
    Dane Garvin Ltd. will provide a Certificate of Attendance to qualified attendees who successfully complete the enduring activity Adaptive Servoventilation in Central Sleep Apnoea: Current Knowledge and Future Perspectives

  •  

  • Educational Grant

    This educational activity is independently produced and is financially supported with an unrestricted educational grant by Philips Respironics.

  • Copyright

    Copyright© Dane Garvin Ltd. All Rights Reserved. Permission for use granted to accreditation providers.

  • Web interface provided by Dane Garvin Ltd.

     

Contact Us